Obesity has become a major public health concern worldwide.
Obesity is linked to the accumulation of fat in the liver, which
can be associated with hepatic inflammation. Non-alcoholic
steatohepatitis (NASH) has become a major liver disease and
reason for liver transplantation. Hans-Jürgen Gruss, MD, PhD,
Vice President, Clinical Development Gastroenterology/
Hepatology and Robert Riccio, PhD, Vice President, Clinical
Development General Medicine, INC Research discuss the
future development of treatments for this hidden disease.